Finance

Lists
Why is FME down 3,16%?
Dive Deeper
FME:ETR
Fresenius Medical Care AG
39,20 €
-3,16%
(-1,28) 1D
29-сен., 17:35:21 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
39,68 €
High
40,21 €
Low
38,94 €
Mkt. cap
10,68 млд
Avg. vol.
785,62 миң
Volume
1,04 млн
Dividend
3,80%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
11,79
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 миң
Open
39,68 €
High
40,21 €
Low
38,94 €
Mkt. cap
10,68 млд
Avg. vol.
785,62 миң
Volume
1,04 млн
Dividend
3,80%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
11,79
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 миң
News stories
From web sources and news partners
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees107 миң
Founded1996
Headquarters-
SectorHealth care provider
Last report
2026-ж., 4-авг.
Fiscal period
Q2 2026
EPS / Est. (EUR)
0,56 € / 0,50 €
+13,11%beat
Revenue / Est. (EUR)
4,86 млд / 4,79 млд
+1,47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,88 млд
5,07 млд
4,61 млд
4,86 млд
Cost of goods sold
3,64 млд
3,68 млд
3,43 млд
3,55 млд
Cost of revenue
3,64 млд
3,68 млд
3,43 млд
3,55 млд
Research and development expenses
37,75 млн
38,63 млн
38,31 млн
39,63 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
705,44 млн
784,62 млн
748,94 млн
736,01 млн
Operating expense
740,50 млн
796,34 млн
803,94 млн
786,35 млн
Total operating expenses
4,38 млд
4,48 млд
4,24 млд
4,34 млд
Operating income
501,72 млн
592,03 млн
375,56 млн
523,63 млн
Other non operating income
-
-
-
-
EBT including unusual items
402,57 млн
508,46 млн
207,52 млн
383,00 млн
EBT excluding unusual items
462,70 млн
541,79 млн
334,44 млн
399,22 млн
Income tax expense
75,22 млн
106,44 млн
42,75 млн
89,83 млн
Effective tax rate
18,69%
20,93%
20,60%
23,45%
Other operating expenses
-2,69 млн
-26,91 млн
16,69 млн
10,71 млн
Net income
274,80 млн
327,08 млн
117,53 млн
218,38 млн
Net profit margin
5,63%
6,45%
2,55%
4,49%
Earnings per share
1,10
1,44
0,91
0,56
Interest and investment income
19,16 млн
13,62 млн
14,62 млн
14,70 млн
Interest expense
-93,10 млн
-99,02 млн
-93,30 млн
-97,55 млн
Net interest expenses
-73,94 млн
-85,40 млн
-78,68 млн
-82,86 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
853,56 млн
780,17 млн
727,79 млн
879,38 млн
Gain or loss from assets sale
50,35 млн
17,92 млн
8,77 млн
-4,09 млн
AI content may include mistakes. Learn more
Google колдонмолору